Abstract
Purpose of Review
To update the knowledge base and effectiveness of clinical interventions to prevent death from pneumonia.
Recent Findings
Integrated management, early identification of danger signs, appropriate care at the appropriate time, and the use of vaccines against respiratory diseases have proven to reduce mortality drastically.
Summary
Most deaths in children less than 5 years of age are from pneumonia in resource-limited environments. Effective strategies such as early detection of signs of danger, access to appropriate care in a timely manner, appropriate antibiotics administered early on, the use of Kangaroo mother care, supplementation of zinc, vaccination and community interventions must to be considered in order to reduce the burden of childhood mortality due to respiratory diseases.
Similar content being viewed by others
References
Danzhen You, Lucia Hug, Simon Ejdemyr, Jan Beise PI, World. Levels and trends in child mortality [Internet]. UNICEF WHO World Bank Group United Nations. 2015. Available from: www.childmortality.org.
Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388:3027–35.
Benguigui Y, Stein F. The Integrated management of Childhood Ilness: an emphasis in the management of Infectious diseses. Semin Infect Dis. 2006;17(2):80–98.
Costello A, Dalgish S. Towards a grand convergence for child survival and health: A strategic review of options for the future building on lessons learnt from IMNCI. WHO. 2016.
Gera T, Shah D, Garner P, Richardson M, Sachdev H. Integrated management of childhood illness (IMCI) strategy for children under five (Review). Cochrane Database Syst Rev. 2016;6.
Rees C. Factors affecting access to healthcare: An observational study of children under 5 years of age presenting to a rural Gambian primary healthcare centre. PLoS One. 2016;11(6):e0157790.
Das JK, Lassi ZS, Salam RA, Bhutta ZA. Effect of community based interventions on childhood diarrhea and pneumonia: uptake of treatment modalities and impact on mortality. BMC Public Health. 2013;13(Suppl 3):S29.
Fisher WC. Quantifying the indirect effects of key child survival interventions for pneumonia, diarrhoea, and measles. Epidemiol Infect. 2013;141(1):115–31.
McCollum ED, King C, Hollowell R, Zhou J, Colbourn T, Nambiar B, et al. Predictors of treatment failure for non-severe childhood pneumonia in developing countries – systematic literature review and expert survey – the first step towards a community focused mHealth risk-assessment tool? BMC Pediatr. 2015;15(1):74.
Jackson S, Mathews KH, Pulanić D, Falconer R, Rudan I, Campbell H, et al. Risk factors for severe acute lower respiratory infections in children – a systematic review and meta-analysis. Croat Med J. 2013;54(2):110–21.
Sonego M. Risk factors for mortality from acute lower respiratory infections (ALRI) in children under five years of age in low and middle-income countries: a systematic review and meta-analysis of observational studies. PLoS One. 2015;10(1):e0116380.
WHO Library Cataloguing–in–Publication Data. World Health Organization. Revised WHO classification and treatment of childhood pneumonia at health facilities: Evidence summaries. 2014.
Lassi ZS, Kumar R, Das JK, Salam RA, Bhutta ZA. Antibiotic therapy versus no antibiotic therapy for children aged two to\n59 months with WHO-defined non-severe pneumonia and wheeze. Cochrane Database Syst Rev. 2014;(5).
Lodha R. Oral antibiotics for community–acquired pneumonia with chest- indrawing in children aged below five years. Indian Pediatr. 2016;53:489–95.
Lassi Z, Das JK, Haider SW, Salam RA, Qazi SA, Bhutta ZA. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age. Arch Dis Child. 2014;99:1–7.
Nascimento-Carvalho CM, Andrade DC, Vilas-Boas A-L. An update on antimicrobial options for childhood community-acquired pneumonia: a critical appraisal of available evidence. Expert Opin Pharmacother. 2015;17(1):53–78.
Lassi Z, Imdad A, Bhutta Z. Short-course versus long-course antibiotic therapy for severe community-acquired pneumonia in children aged 2 months to 59 months (Review). Cochrane Libr. 2015;(6).
Onakpoya IJ, Hayward G, Heneghan CJ. Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under. Cochrane Database Syst Rev. 2015;(9).
Qiu S, Shen Y, Pan H, Wang J, Zhang Q. Effectiveness and safety of oseltamivir for treating influenza: an updated meta-analysis of clinical trials. Infect Dis (Auckl). 2015;(July):1–12.
Rojas-Reyes MX, Granados Rugeles C, Patricia Charry-Anzola L, Rojas-Reyes MX, Granados Rugeles C, Charry-Anzola LP. Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age. Cochrane Database Syst Rev. 2014;12(12):5975.
Chaves G, Fregonezi GAF, Dias FAL, Ribeiro CTD, Guerra RO, Freitas DA, et al. Chest physiotherapy for pneumonia in children. Cochrane Database Syst Rev. 2013;9(9):CD010277.
Lassi Z, Bhutta Z. Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes (Review). Cochrane Database Syst Rev. 2015;3:CD007754.
Seguin M, Niño M. Non-clinical interventions for acute respiratory infections and diarrhoeal diseases among young children in developing countries. Trop Med Int Heal. 2015;20(2):146–69.
Oyo-Ita A, Wiysonge C, Oringanje C, Nwachukwu CEC, Oduwole O, Meremikwu MMM, et al. Interventions for improving coverage of childhood immunisation in low- and middle-income countries (Review). Cochrane database Syst Rev. 2016;7.
Lafond KE, Nair H, Rasooly MH, Valente F, Booy R, Rahman M, et al. Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic Analysis. PLoS Med. 2016;13(3):1–19.
AAP Committee on Infectious Diseases. Recommendations for Prevention and Control of Influenza in Children, 2016-2017. Pediatrics. 2016;138(4):e20162527.
Aigbogun NW, Hawker JI, Stewart A. Interventions to increase influenza vaccination rates in children with high-risk conditions-A systematic review. Vaccine. Elsevier Ltd. 2015;33(6):759–70.
Su WJ, Chan TC, Chuang PH, Liu YL, Lee PI, Liu MT, et al. Estimating influenza vaccine effectiveness using routine surveillance data among children aged 6-59 months for five consecutive influenza seasons. Int J Infect Dis. International Society for Infectious Diseases. 2015;30:115–21.
Remschmidt C, Wichmann O, Harder T. Influenza vaccination in HIV-infected individuals: Systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety. Vaccine. 2014;32(43):5585–92.
Gill PJ, Ashdown HF, Wang K, Heneghan C, Roberts NW, Harnden A, et al. Identification of children at risk of influenza-related complications in primary and ambulatory care: A systematic review and meta-analysis. Lancet Respir Med. Elsevier Ltd. 2015;3(2):139–9.
Salam RA, Das JK, Dojo Soeandy C, Lassi ZS, Bhutta ZA. Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes. Cochrane Database Syst Rev. 2015;(6).
Prutsky GJ, Domecq JP, Elraiyah T, Prokop LJ, Murad MH. Live Attenuated Influenza Vaccine in Children Younger than 2 years. A systematic review. Pediatr Infect Dis J. 2014;33(4):106–15.
Lam W, Dawson A, Fowler C. Health promotion interventions to prevent early childhood human influenza at the household level: A realist review to identify implications for programmes in Hong Kong. J Clin Nurs. 2015;24:891–905.
WHO. Pneumococcal Disease [Internet]. 2015. 2015 [cited 2017 May 11]. Available from: http://www.who.int/biologicals/vaccines/pneumococcal/en/.
Ewald H. The clinical effectiveness of Pneumococcal conjugate vaccines: A systematic review and meta-analysis of randomized controlled trials. Dtsch Arztebl Int. 2016;113(9):139–46.
Conklin L, Loo JD, Kirk J, Fleming-Dutra KE, Deloria Knoll M, Park DE, et al. Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Invasive Pneumococcal Disease Among Young Children. Pediatr Infect Dis J. 2014;33(1):109–18.
Loo JD, Conklin L, Fleming-Dutra KE, Deloria Knoll M, Park DE, Kirk J, et al. Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Prevention of Pneumonia. Pediatr Infect Dis J. 2014;33(1):140–51.
Chaithongwongwatthana S, Yamasmit W, Limpongsanurak S, Lumbiganon P, Tolosa J. Pneumococcal vaccination during pregnancy for preventing infant infection ( Review ). Cochrane Database Syst Rev. 2015;1.
Brennhofer S, Reifsnider E, Bruening M. Malnutrition coupled with diarrheal and respiratory infections among children in Asia: A systematic review. Public Health Nurs. 2017;34(4):401–9.
Kristjansson E, Dk F, Liberato S, M BJ, Welch V, Batal M, et al. Food supplementation for improving the physical and psychosocial health of socio-economically disadvantaged children aged three months to five years (Review). Cochrane Database Syst Rev. 2015;(3).
Sankar MJ, Sinha B, Chowdhury R, Bhandari N, Taneja S, Martines J, et al. Optimal breastfeeding practices and infant and child mortality: a systematic review and meta-analysis. Acta Paediatr. 2015;104:3–13.
Lamberti LM, Zakarija-Grković I, Fischer Walker CL, Theodoratou E, Nair H, Campbell H, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health. 2013;13(Suppl 3):S18.
Khan J, Vesel L, Bahl R, Martines JC. Timing of Breastfeeding Initiation and Exclusivity of Breastfeeding During the First Month of Life: Effects on Neonatal Mortality and Morbidity - A Systematic Review and Meta-analysis. Matern Child Health J. 2014;19(3):468–79.
Walters D, Horton S, Siregar AYM, Pitriyan P, Hajeebhoy N, Mathisen R, et al. The cost of not breastfeeding in Southeast Asia. Health Policy Plan. 2016;0(0):1–10.
Conde-Agudelo A, Diaz-Rosello J. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants. Cochrane Database Syst Rev. 2014;22(4).
Imdad A, Ahmed Z, Bhutta Z. Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less. Cochrane Database Syst Rev. 2016;9.
Lassi Z, Moin A, Bhutta Z. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev. 2016;(12).
Mayo-Wilson E, Imdad A, Junior J, Dean S, Bhutta ZA. Preventive zinc supplementation for children, and the effect of additional iron: a systematic review and meta-analysis. BMJ Open. 2014;4(6):4647.
Fu W, Ding L-R, Zhuang C, Zhou Y-H. Effects of Zinc supplementation on the Incidence of mortality in preschool children: A meta-analysis of randomized controlled trials. PLoS One. 2013;8(11):e79998.
Tie H-T, Tan Q, Ming-zhu L, Li Q, Jia-lin Y, Qing-chen W. Zinc as an adjunct to antibiotics for the treatment of severe pneumonia in children <5 years : a meta-analysis of randomised-controlled trials. Br J Nutr. 2016;115:807–16.
Mao S, Zhang A, Huang S. Meta-analysis of Zn, Cu and Fe in the hair of Chinese children with recurrent respiratory tract infection. Scand J Clin Lab Invest. 2014;74(7):561–7.
de Araujo G, de Oliveira JM, Peixoto D, Sarinho E. Probiotics for the treatment of upper and lower respiratory-tract infections in children: Systematic review based on randomized clinical trials. J Pediatr (Rio J). 2015;1–15.
Feng H, Xun P, Pike K, Wills AK, Chawes BL, Bisgaard H, et al. In utero exposure to 25-hydroxyvitamin D and risk of childhood asthma, wheeze, and respiratory tract infections: A meta-analysis of birth cohort studies. Journal of Allergy and Clinical Immunology. Elsevier Ltd; 2017. 1508-17 p.
Lindegren M. Integration of HIV/AIDS services with maternal, neonatal and child health, nutrition, and family planning services. Cochrane Database Syst Rev. 2012;12(9):451–3.
Theodoratou E, McAllister DA, Reed C, Adeloye DO, Rudan I, Muhe LM, et al. Global, regional, and national estimates of pneumonia burden in HIV-infected children in 2010: A meta-analysis and modelling study. Lancet Infect Dis. World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved.; 2014;14(12):1250–8.
Zunza M, Mercer GD, Thabane L, Esser M, Cotton MF. Effects of postnatal interventions for the reduction of vertical HIV transmission on infant growth and non-HIV infections: A systematic review. J Int AIDS Soc. 2013;16:1–12.
Dangour A, Watson L, Cumming O, Boisson S, Che Y, Velleman Y, et al. Interventions to improve water quality and supply , sanitation and hygiene practices, and their effects on the nutritional status of children (Review). Cochrane Database Syst Rev. 2013;(8).
Bruce NG, Dherani MK, Das JK, Balakrishnan K, Adair-Rohani H, Bhutta ZA, et al. Control of household air pollution for child survival: estimates for intervention impacts. BMC Public Health. 2013;13(3):8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Carlos Arreaza, Dan Arreaza-Kaufman, Jeanette Coriat, Iris Kaufman, and Fernando Stein declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Pediatric Global Health
Rights and permissions
About this article
Cite this article
Arreaza, C., Arreaza, D., Coriat, J. et al. Update on Prevention Efforts for Pneumonia Attributed Deaths in Children Under 5 Years of Age. Curr Trop Med Rep 5, 16–23 (2018). https://doi.org/10.1007/s40475-018-0138-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40475-018-0138-6